- Home
- RAYA vs CASI Comparison
RAYA vs CASI Comparison
Compare RAYA & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAYA | CASI |
|---|---|---|
| Founded | 2019 | 1991 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 24.9M |
| IPO Year | 2022 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RAYA | CASI |
|---|---|---|
| Price | $3.69 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 28.9K | ★ 30.0K |
| Earning Date | 04-17-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,101,325.00 | $26,846,000.00 |
| Revenue This Year | $20.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.78 | ★ 21.72 |
| 52 Week Low | $3.13 | $0.75 |
| 52 Week High | $736.99 | $3.29 |
Technical Indicators
Market Signals| Indicator | RAYA | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 42.70 |
| Support Level | $3.64 | $0.81 |
| Resistance Level | $4.04 | $0.91 |
| Average True Range (ATR) | 0.32 | 0.07 |
| MACD | -0.06 | 0.03 |
| Stochastic Oscillator | 36.89 | 55.56 |
Price Performance
Historical ComparisonAbout RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.